Literature DB >> 20015666

A review of 51 talonavicular joint arthrodeses for flexible pes valgus deformity.

Craig A Camasta1, Christopher R D Menke, Patrick B Hall.   

Abstract

The purpose of this study was to evaluate the radiographic and clinical outcomes of isolated talonavicular arthrodesis in the treatment of the flexible pes valgus foot type. Retrospectively, 51 consecutive isolated talonavicular arthrodeses in 41 patients were evaluated. The mean patient age was 47 (range 9 to 72) years, and the mean follow-up duration was 43.3 (range 11 to 113) months. The mean 10-cm categorical pain score before the surgery was 7.60 +/- 2.37, and this improved to 1.90 +/- 2.38 postoperatively, and this difference was statistically significant (P < .001). We also measured the preoperative and postoperative percent of talar uncovering, calcaneocuboid angle, Kite's angle, talar dome height, calcaneal inclination angle, and Meary's angle, and observed statistically significant (P < .001) improvements in all of these. Fifty-one (100%) of the cases progressed to radiographic osseous union, although 2 (3.92%) of the cases were considered delayed unions. Moreover, 4 (7.84%) of the cases displayed juxta-articular arthrosis postoperatively, and 2 (3.9%) cases developed transfer pain to the lateral column. The authors concluded that isolated talonavicular arthrodesis is a safe and effective procedure for the treatment of painful pes valgus deformity. Copyright 2010 American College of Foot and Ankle Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 20015666     DOI: 10.1053/j.jfas.2009.08.016

Source DB:  PubMed          Journal:  J Foot Ankle Surg        ISSN: 1067-2516            Impact factor:   1.286


  1 in total

1.  Osteoarthritis of the talonavicular joint with pseudarthrosis of the navicular bone: a case report.

Authors:  Noriyuki Kanzaki; Takayuki Nishiyama; Takaaki Fujishiro; Shinya Hayashi; Yoshiyuki Takakura; Yoshinori Takakura; Masahiro Kurosaka
Journal:  J Med Case Rep       Date:  2011-11-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.